Glaub Kathleen Sereda 4
4 · IO Biotech, Inc. · Filed Jun 7, 2024
Insider Transaction Report
Form 4
IO Biotech, Inc.IOBT
Glaub Kathleen Sereda
Director
Transactions
- Award
Stock Option (Right to Buy)
2024-06-06+45,642→ 45,642 totalExercise: $1.25Exp: 2034-06-06→ Common Stock (45,642 underlying)
Footnotes (1)
- [F1]These options vest on June 6, 2025, subject to the reporting person's continued service through the applicable vesting date, and subject to 100% acceleration upon a change of control.